Mitochondrial RNA methylation in cancer

Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189213. doi: 10.1016/j.bbcan.2024.189213. Epub 2024 Nov 7.

Abstract

Mitochondria have a complete and independent genetic system with necessary biological energy for cancer occurrence and persistence. Mitochondrial RNA (mt-RNA) methylation, as a frontier in epigenetics, has linked to cancer progression with growing evidences. This review has comprehensively summarized detailed mechanisms of mt-RNA methylation in regulating cancer proliferation, metastasis, and immune infiltration from the mt-RNA methylation sites, biological significance, and its methyltransferases. The mt-RNA methylation also plays a very significant role via epigenetic crosstalk between nucleus and mitochondria. Importantly, the unique structures and functional characteristics of mt-RNA methyltransferases and the potential targeting treatment drugs for cancer are also analyzed. Revealing human mt-RNA methylation regulatory system and the relationship with cancer will contribute to identifying potential biomarkers and therapeutic targets for precise prevention, detection, intervention and treatment in the future.

Keywords: Cancer; Drugs; Mitochondrial RNA methylation; Mitochondrial RNA methyltransferase; Nuclear-mitochondrial crosstalk.

Publication types

  • Review

MeSH terms

  • Animals
  • Epigenesis, Genetic*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Methylation
  • Mitochondria* / genetics
  • Mitochondria* / metabolism
  • Mitochondria* / pathology
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • RNA, Mitochondrial* / genetics
  • RNA, Mitochondrial* / metabolism

Substances

  • RNA, Mitochondrial